Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor.
Authors:
- W F RosseWRW F Rosse
Open Access
- 1 June 1994
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 93 (6) , 2305-2310
Abstract
Although the clinical syndrome of paroxysmal nocturnal hemoglobinuria (PNH)' was recognized many years ago (1), its complexity was difficult to explain. The erythrocytes were known to be susceptible to the hemolytic action of complement , and this characteristic formed the basis for the diagnosis of the disease (2). In addition, many patients suffered thromboses and/or had evidence of relative or absolute diminution in hematopoiesis (3). Although the disease appeared to be acquired, no specific lesion could be delineated which could account for the complex clinical symptoms. The first identified biochemical defects were the absence of two enzymes: acetylcholinesterase from the red cells (4) and alkaline phosphatase from the leukocytes (5, 6). Considerably later, the absence of the complement regulatory protein, decay accelerating factor (DAF), was identified (7). To date, at least 14 proteins have been found to be missing or markedly diminished on the abnormal blood cells in PNH (Table I). For many of these, functions are known, and the lack of those functions may be related to the pathogenesis of PNH; in other cases, the function of the missing protein is not known. Further, it is likely that other proteins, as yet unidentified, are probably also missing. The recognition, first, that alkaline phosphatase (8) and, later, that DAF (9) were tethered to the plasma membrane by a glycosylphosphatidylinositol anchor directed research on the pathogenesis of the defects in PNH to the biosynthesis of that molecule. The glycosylphosphatidylinositol anchor and its biosynthesis A large number of eukaryotic proteins are attached to the cell surface by novel glycolipids called glycosylphosphatidylinosi-tols (GPIs) (10-13). This type of glycolipid constitutesKeywords
This publication has 77 references indexed in Scilit:
- A deficiency in CDw52 (CAMPATH-1 antigen) of paroxysmal nocturnal hemoglobinuria lymphocytes.1993
- Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.1993
- THE STRUCTURE AND BIOSYNTHESIS OF GLYCOSYL PHOSPHATIDYLINOSITOL PROTEIN ANCHORSAnnual Review of Biochemistry, 1993
- Early lipid intermediates in glycosyl-phosphatidylinositol anchor assembly are synthesized in the ER and located in the cytoplasmic leaflet of the ER membrane bilayer.Journal of Cell Biology, 1993
- Complexity of ethanolamine phosphate addition in the biosynthesis of glycosylphosphatidylinositol anchors in mammalian cells.Journal of Biological Chemistry, 1992
- Glycosyl‐phosphatidylinositol: a versatile anchor for cell surface proteins 1The FASEB Journal, 1989
- TAP transcription and phosphatidylinositol linkage mutants are defective in activation through the T cell receptorCell, 1988
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.Journal of Experimental Medicine, 1986
- STUDIES ON PHOSPHATIDYLINOSITOL PHOSPHODIESTERASE (PHOSPHOLIPASE-C TYPE) OF BACILLUS-CEREUS .1. PURIFICATION, PROPERTIES AND PHOSPHATASE-RELEASING ACTIVITY1976
- Erythrocyte Acetylcholinesterase Deficiency in Paroxysmal Nocturnal Hemoglobinuria (PNH)—A Comparison of the Complement-Sensitive and Insensitive PopulationsBlood, 1969